This Is What Whales Are Betting On Moderna
Portfolio Pulse from Benzinga Insights
Significant investors have taken a predominantly bearish stance on Moderna (NASDAQ:MRNA), with options data revealing 75% bearish sentiment. The targeted price range for MRNA is between $60.0 and $100.0. Despite this, the current price of MRNA is $93.85, down 3.73%, with neutral RSI indicators. Analysts have mixed opinions, with a consensus target price of approximately $100.67, varying ratings from 'Outperform' to 'Reduce'. Moderna's mRNA technology has seen rapid validation, especially with its COVID-19 vaccine, and it continues to explore various therapeutic areas.
February 29, 2024 | 5:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Large investors are predominantly bearish on Moderna, with a significant portion of options trades indicating a bearish sentiment. The stock is currently down 3.73% at $93.85, with analysts providing mixed ratings and a consensus target price of around $100.67.
The bearish sentiment among significant investors, indicated by the options data, suggests a potential short-term downward pressure on MRNA's stock price. However, the mixed analyst ratings and the current price nearing the lower end of the targeted range may limit the extent of the decline.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100